Scarica l'app Stockscreener
4.14
1.19%
-0.05
Dopo l'orario di chiusura:
4.07
-0.07
-1.69%
Clene Inc Borsa (CLNN) Ultime notizie
Clene (NASDAQ:CLNN): Why Is Clinical Evidence in Focus Today? - Kalkine Media
CLNN Looks 375.9% Overvalued on GF Value™ - GuruFocus
CLNN Stock Rises 8% – Here’s What The FDA Update Means For Clene’s ALS Treatment - Stocktwits
Clene (NASDAQ:CLNN) Announces Quarterly Earnings Results, Misses Estimates By $0.71 EPS - MarketBeat
Clene Releases Q2 2026 Financial Results - AlphaStreet
Vivo Opportunity entities disclose 9.99% Clene Inc. (CLNN) stake via warrants - Stock Titan
Clene Inc. (CLNN) grants 4,872 stock options to director Alison Mosca - Stock Titan
Clene Inc. (CLNN) grants director Arjun Desai 3,674 options at $4.19 strike - Stock Titan
Clene Inc. (CLNN) director receives 6,230 stock options at $4.19 strike - Stock Titan
Clene Inc. (CLNN) awards director Shalom Jacobovitz 4,752 stock options at $4.19 - Stock Titan
Clene Inc. (CLNN) director receives 3,514 stock options vesting immediately at $4.19 - Stock Titan
Clene Inc. (CLNN) director granted 3,514 stock options at $4.19 strike - Stock Titan
Clene Q2 FY26 net loss widens 81% to $13.42 million - Bitget
Clene Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Clene Inc. (CLNN) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Form 8K Clene Inc. For: 14 August By Investing.com - Investing.com Canada
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights - The Manila Times
Clene Inc. (NASDAQ: CLNN) widens Q2 loss while preparing accelerated ALS NDA - Stock Titan
ALS patients whose nerve marker declined or stabilized lived longer, Clene says - Stock Titan
CLNN: Net loss widened to $13.4M in Q2 2026, with ongoing funding concerns and rising R&D costs - TradingView
Clene Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CLNN Q2'26 Earnings: EPS estimate is (0.37) USD - TradingView
Clene Targets Early Q4 NDA Filing for CNM-Au8 in ALS - MarketBeat
Clene Nanomedicine at canaccord growth conference: FDA path in focus By Investing.com - Investing.com Canada
Clene Inc. (CLNN) holder Ugwumba exits, reports 0% beneficial stake - Stock Titan
Clene Inc. (NASDAQ:CLNN) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Clene reports survival benefit in ALS patients with NfL response By Investing.com - Investing.com UK
Empery Asset Management, LP Buys Clene Inc (CLNN) -- Shares Look 486% Overvalued on GF Value - GuruFocus
Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval - Investing News Network
Clene Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView
Clene reports survival benefit in ALS patients with NfL response - Investing.com
Form 8K Clene Inc. For: 10 August By Investing.com - Investing.com Australia
Clene (CLNN) ties CNM-Au8 ALS survival gains to NfL biomarker for planned NDA - Stock Titan
Clene ALS Trial Links Nerve-Injury Marker to Nearly 6-Month Survival Gain - Stock Titan
CLNN Q2'26 Earnings: revenue estimate is 61.00K USD - TradingView
Clene Inc. (CLNN) Stock News Today - TradingKey
Clene Inc. (CLNN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clene Inc. (CLNN) insider relinquishes 799,358 warrant rights in fund shift - Stock Titan
Clene (CLNN) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Empery Asset Management (CLNN) discloses 7.17% beneficial stake in Clene - Stock Titan
Clene Inc. (CLNN) Institutional Confidence - TradingKey
Nanotechnology Stocks To ConsiderJuly 30th - MarketBeat
Clene to Present at The Canaccord 46th Annual Growth Conference - The Manila Times
Nanotechnology Stocks To Watch TodayJuly 29th - MarketBeat
Best Nanotechnology Stocks Worth WatchingJuly 27th - MarketBeat
Clene Inc. (CLNN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CLNN|Clene Inc.|Price:5.410|Chg%:+0.020 - TradingKey
Clene Inc. (CLNN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clene Inc. (CLNN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clene Inc. (CLNN) Balance Sheet - TradingKey
Top Nanotechnology Stocks To Keep An Eye OnJuly 26th - MarketBeat
Clene Inc. (CLNN) Income Statement - TradingKey
Clene Inc CLNN Slips 164 as Stock Consolidates Near Key SupportMarket Intelligence - po-news-eg.net
Clene Inc. (CLNN) Slips 1.64% as Stock Consolidates Near Key SupportParabolic SAR - dars.gov.et
CLNN Options Chain — NASDAQ:CLNN - TradingView
Clene Inc. (CLNN) Cash Flow - TradingKey
CLNN Options Volatility — NASDAQ:CLNN - TradingView
CLNN Stock Falls After Roth Labels Accelerated Approval For ALS Drug A ‘Long Shot’ - Stocktwits
Nanotechnology Stocks To Watch NowJuly 24th - MarketBeat
Best Nanotechnology Stocks To ResearchJuly 23rd - MarketBeat
Top Nanotechnology Stocks To ResearchJuly 22nd - MarketBeat
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):